Skip to Main Content

++

Chapter 36. Intervention in Venous and Arterial Grafts

++
++
++

The use of embolic protection in saphenous vein graft (SVG) stent implantation in the randomized SAFER trial was associated with which of the following outcomes?

++
++
++

A. No impact on occurrence of major adverse cardiac events (MACE)

++
++

B. 10% reduction in MACE

++
++

C. 20% reduction in MACE

++
++

D. 40% reduction in MACE

+
++

The correct answer is D

++
++
++

The rate of SVG failure at 1 year after coronary artery bypass graft (CABG) in routinely performed angiographic studies was shown to be which of the following?

++
++
++

A. 5%

++
++

B. 10%

++
++

C. 15%

++
++

D. ≥20%

+
++

The correct answer is D

++
++
++

Use of slightly oversized stents in SVGs has been associated with which of the following outcomes?

++
++
++

A. Reduced target vessel revascularization

++
++

B. Reduced periprocedural infarction

++
++

C. Increased periprocedural MACE

++
++

D. Reduced restenosis

+
++

The correct answer is C

++
++
++

Use of drug-eluting stents in SVGs compared to bare metal stents was associated with which of the following in randomized trials?

++
++
++

A. Reduced mortality

++
++

B. Reduced myocardial infarction

++
++

C. Reduced stent thrombosis

++
++

D. Reduced restenosis

+
++

The correct answer is D

++
++
++

When used in SVGs prior to stent implantation, atheroablative strategies were shown to be associated with which of the following?

++
++
++

A. Increased cost and reduced restenosis

++
++

B. Increased cost and similar restenosis

++
++

C. Similar cost and outcome

++
++

D. Increased complications

+
++

The correct answer is B

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.